進行性骨化性線維異形成症 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "進行性骨化性線維異形成症" in Japanese language version.

refsWebsite

Global rank Japanese rank

4doi.org

2^nd place

6^th place

4nih.gov

4^th place

24^th place

3nikkei.com

211^th place

13^th place

1muttermuseum.org

low place

1jiji.com

692^nd place

43^rd place

1sankei.com

323^rd place

15^th place

1kobe-np.co.jp

2,514^th place

158^th place

1web.archive.org

1^st place

1kyoto-np.co.jp

3,792^nd place

249^th place

1worldcat.org

5^th place

19^th place

1bmj.com

1,226^th place

1,988^th place

1nature.com

234^th place

363^rd place

1upenn.edu

702^nd place

2,232^nd place

1wiley.com

222^nd place

498^th place

bmj.com (Global: 1,226^th place; Japanese: 1,988^th place)

jmg.bmj.com

Connor JM, Evans DA (1982). “Genetic aspects of fibrodysplasia ossificans progressiva” (abstract). J. Med. Genet. 19 (1): 35–39. doi:10.1136/jmg.19.1.35. PMC 1048816. PMID 7069743.

doi.org (Global: 2^nd place; Japanese: 6^th place)

Maruyama, Rika; Nguyen, Quynh; Roshmi, Rohini Roy; Touznik, Aleksander; Yokota, Toshifumi (2022-06). “Allele-Selective LNA Gapmers for the Treatment of Fibrodysplasia Ossificans Progressiva Knock Down the Pathogenic ACVR1R206H Transcript and Inhibit Osteogenic Differentiation”. Nucleic Acid Therapeutics 32 (3): 185–193. doi:10.1089/nat.2021.0009. ISSN 2159-3345. PMID 35085461.
Connor JM, Evans DA (1982). “Genetic aspects of fibrodysplasia ossificans progressiva” (abstract). J. Med. Genet. 19 (1): 35–39. doi:10.1136/jmg.19.1.35. PMC 1048816. PMID 7069743.
Shore EM, Xu M, Feldman GJ et al. (2006). “A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva” (abstract). Nat. Genet. 38 (5): 525–527. doi:10.1038/ng1783. PMID 16642017.
Dinther et al. (2010). “ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation”. Journal of Bone and Mineral Research: 091211115834058–35. doi:10.1359/jbmr.091110.

jiji.com (Global: 692^nd place; Japanese: 43^rd place)

難病１７歳「ゴールまだ先」＝ｉＰＳ研究に協力－兵庫 - 時事ドットコム^{[リンク切れ]}

kobe-np.co.jp (Global: 2,514^th place; Japanese: 158^th place)

“iPS創薬の治験開始　骨の難病、明石のYさんに世界初”. 神戸新聞. (2017年10月5日) 2017年10月5日閲覧。 ^{[リンク切れ]}

kyoto-np.co.jp (Global: 3,792^nd place; Japanese: 249^th place)

"９月にもｉＰＳ創薬治験　山中京大教授「活発化に期待」". 京都新聞. (2017年8月1日). http://www.kyoto-np.co.jp/environment/article/20170801000094^{[リンク切れ]}

muttermuseum.org (Global: low place; Japanese: low place)

memento.muttermuseum.org

“Fibrodysplasia Ossificans Progressiva” (英語). Mütter Museum. 2022年9月13日閲覧。※ムッター博物館による解説。

nature.com (Global: 234^th place; Japanese: 363^rd place)

Shore EM, Xu M, Feldman GJ et al. (2006). “A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva” (abstract). Nat. Genet. 38 (5): 525–527. doi:10.1038/ng1783. PMID 16642017.

nih.gov (Global: 4^th place; Japanese: 24^th place)

pubmed.ncbi.nlm.nih.gov

Maruyama, Rika; Nguyen, Quynh; Roshmi, Rohini Roy; Touznik, Aleksander; Yokota, Toshifumi (2022-06). “Allele-Selective LNA Gapmers for the Treatment of Fibrodysplasia Ossificans Progressiva Knock Down the Pathogenic ACVR1R206H Transcript and Inhibit Osteogenic Differentiation”. Nucleic Acid Therapeutics 32 (3): 185–193. doi:10.1089/nat.2021.0009. ISSN 2159-3345. PMID 35085461.
Connor JM, Evans DA (1982). “Genetic aspects of fibrodysplasia ossificans progressiva” (abstract). J. Med. Genet. 19 (1): 35–39. doi:10.1136/jmg.19.1.35. PMC 1048816. PMID 7069743.
Shore EM, Xu M, Feldman GJ et al. (2006). “A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva” (abstract). Nat. Genet. 38 (5): 525–527. doi:10.1038/ng1783. PMID 16642017.

pmc.ncbi.nlm.nih.gov

Connor JM, Evans DA (1982). “Genetic aspects of fibrodysplasia ossificans progressiva” (abstract). J. Med. Genet. 19 (1): 35–39. doi:10.1136/jmg.19.1.35. PMC 1048816. PMID 7069743.

nikkei.com (Global: 211^th place; Japanese: 13^th place)

sankei.com (Global: 323^rd place; Japanese: 15^th place)

“「新薬の治験に参加したい」皮膚を提供のFOP患者、Yさん、京都大の研究グループに期待”. 産経新聞. (2017年8月1日) 2017年8月3日閲覧。

upenn.edu (Global: 702^nd place; Japanese: 2,232^nd place)

uphs.upenn.edu

News Release of FOP's Cause^{[リンク切れ]}

web.archive.org (Global: 1^st place; Japanese: 1^st place)

“iPS使い創薬、初の治験へ＝骨の難病患者に－9月以降、4大学病院で・京大”. 時事通信社. (2017年8月1日) 2017年8月1日閲覧。 ^{[リンク切れ]}

wiley.com (Global: 222^nd place; Japanese: 498^th place)

onlinelibrary.wiley.com

Dinther et al. (2010). “ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation”. Journal of Bone and Mineral Research: 091211115834058–35. doi:10.1359/jbmr.091110.

worldcat.org (Global: 5^th place; Japanese: 19^th place)

search.worldcat.org

Maruyama, Rika; Nguyen, Quynh; Roshmi, Rohini Roy; Touznik, Aleksander; Yokota, Toshifumi (2022-06). “Allele-Selective LNA Gapmers for the Treatment of Fibrodysplasia Ossificans Progressiva Knock Down the Pathogenic ACVR1R206H Transcript and Inhibit Osteogenic Differentiation”. Nucleic Acid Therapeutics 32 (3): 185–193. doi:10.1089/nat.2021.0009. ISSN 2159-3345. PMID 35085461.

進行性骨化性線維異形成症 (Japanese Wikipedia)

bmj.com (Global: 1,226th place; Japanese: 1,988th place)

jmg.bmj.com

doi.org (Global: 2nd place; Japanese: 6th place)

jiji.com (Global: 692nd place; Japanese: 43rd place)

kobe-np.co.jp (Global: 2,514th place; Japanese: 158th place)

kyoto-np.co.jp (Global: 3,792nd place; Japanese: 249th place)